Paul E. Gold
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paul E. Gold has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ken A. Morris
Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA
2 shared publicationsQing Chang
Department of Psychology, University of Illinois at Urbana-Champaign, 603 E. Daniel St., Champaign, IL 61820, USA
2 shared publicationsRenee N. Sadowski
Neuroscience Program, College of Medicine, University of Illinois at Urbana-Champaign, Champaign, IL 61820, United States
2 shared publicationsAmanda J. Quisenberry
1 shared publicationClint E. Canal
Neuroscience Program, College of Medicine, University of Illinois at Urbana-Champaign, Champaign, IL 61820, United States
1 shared publicationClinton E. Canal
Neuroscience Program, University of Illinois, Urbana-Champaign, Illinois 61820, USA
1 shared publication
Latest Publications
- 1 May 2012
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 133 (5) , 291-299
Age-related impairments in memory and in CREB and pCREB expression in hippocampus and amygdala following inhibitory avoidance training
- 1 May 2012
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 133 (5) , 291-299
Age-related impairments in memory and in CREB and pCREB expression in hippocampus and amygdala following inhibitory avoidance training
- 1 October 2011
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 96 (3) , 498-503
Acetylcholine release in the hippocampus and prelimbic cortex during acquisition of a socially transmitted food preference
- 1 October 2011
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 96 (3) , 498-503
Acetylcholine release in the hippocampus and prelimbic cortex during acquisition of a socially transmitted food preference
- 30 September 2011
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 96 (2) , 136-142
Lidocaine attenuates anisomycin-induced amnesia and release of norepinephrine in the amygdala
- 30 September 2011
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 96 (2) , 136-142
Lidocaine attenuates anisomycin-induced amnesia and release of norepinephrine in the amygdala
- 1 December 2010
- Published by Elsevier in Neurobiology of Aging
- Vol. 31 (12) , 2136-2145
Age-related memory impairments due to reduced blood glucose responses to epinephrine
- 1 December 2010
- Published by Elsevier in Neurobiology of Aging
- Vol. 31 (12) , 2136-2145
Age-related memory impairments due to reduced blood glucose responses to epinephrine
- 1 December 2009
- Published by Elsevier in Behavioural Brain Research
- Vol. 205 (1) , 19-25
Effects of stress, corticosterone, and epinephrine administration on learning in place and response tasks
- 1 December 2009
- Published by Elsevier in Behavioural Brain Research
- Vol. 205 (1) , 19-25
Effects of stress, corticosterone, and epinephrine administration on learning in place and response tasks
- 26 August 2008
- Published by Cold Spring Harbor Laboratory in Learning & Memory
- Vol. 15 (9) , 677-686
Intra-amygdala injections of CREB antisense impair inhibitory avoidance memory: Role of norepinephrine and acetylcholine
Infusions of CREB antisense into the amygdala prior to training impair memory for aversive tasks, suggesting that the antisense may interfere with CRE-mediated gene transcription and protein synthesis important for the formation of new memories within the amygdala. However, the amygdala also appears to modulate memory formation in distributed brain sites, through mechanisms that include the release of norepinephrine and acetylcholine within the amygdala. Thus, CREB antisense injections may affect memory by interfering with mechanisms of modulation, rather than storage, of memory. In the present experiment, rats received bilateral intra-amygdala infusions of CREB antisense (2 nmol/1 μL) 6 h prior to inhibitory avoidance training. In vivo microdialysis samples were collected from the right amygdala before, during, and following training. CREB antisense produced amnesia tested at 48 h after training. In addition, CREB antisense infusions dampened the training-related release of norepinephrine, and to a lesser extent of acetylcholine, in the amygdala. Furthermore, intra-amygdala infusions of the β-adrenergic receptor agonist clenbuterol administered immediately after training attenuated memory impairments induced by intra-amygdala injections of CREB antisense. These findings suggest that intra-amygdala treatment with CREB antisense may affect processes involved in modulation of memory in part through interference with norepinephrine and acetylcholine neurotransmission in the amygdala.
- 26 August 2008
- Published by Cold Spring Harbor Laboratory in Learning & Memory
- Vol. 15 (9) , 677-686
Intra-amygdala injections of CREB antisense impair inhibitory avoidance memory: Role of norepinephrine and acetylcholine
Infusions of CREB antisense into the amygdala prior to training impair memory for aversive tasks, suggesting that the antisense may interfere with CRE-mediated gene transcription and protein synthesis important for the formation of new memories within the amygdala. However, the amygdala also appears to modulate memory formation in distributed brain sites, through mechanisms that include the release of norepinephrine and acetylcholine within the amygdala. Thus, CREB antisense injections may affect memory by interfering with mechanisms of modulation, rather than storage, of memory. In the present experiment, rats received bilateral intra-amygdala infusions of CREB antisense (2 nmol/1 μL) 6 h prior to inhibitory avoidance training. In vivo microdialysis samples were collected from the right amygdala before, during, and following training. CREB antisense produced amnesia tested at 48 h after training. In addition, CREB antisense infusions dampened the training-related release of norepinephrine, and to a lesser extent of acetylcholine, in the amygdala. Furthermore, intra-amygdala infusions of the β-adrenergic receptor agonist clenbuterol administered immediately after training attenuated memory impairments induced by intra-amygdala injections of CREB antisense. These findings suggest that intra-amygdala treatment with CREB antisense may affect processes involved in modulation of memory in part through interference with norepinephrine and acetylcholine neurotransmission in the amygdala.
- 1 January 2006
- Published by American Psychological Association (APA)
Differences in Innate Food Preference Between Rat Strains
- 1 January 2006
- Published by American Psychological Association (APA)
Differences in Innate Food Preference Between Rat Strains